IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,317,000 | -71.9% | 137,500 | -27.7% | 0.00% | -50.0% |
| Q3 2021 | $4,692,000 | -82.4% | 190,300 | -81.4% | 0.00% | -82.6% |
| Q2 2021 | $26,656,000 | +1108.9% | 1,024,400 | +1369.8% | 0.02% | +1050.0% |
| Q1 2021 | $2,205,000 | -18.2% | 69,696 | +20.0% | 0.00% | 0.0% |
| Q4 2020 | $2,696,000 | +294.7% | 58,069 | +179.9% | 0.00% | – |
| Q3 2020 | $683,000 | -12.9% | 20,745 | -27.7% | 0.00% | -100.0% |
| Q2 2020 | $784,000 | -33.6% | 28,700 | -32.7% | 0.00% | 0.0% |
| Q4 2019 | $1,180,000 | – | 42,637 | +426270.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 10 | -94.3% | 0.00% | – |
| Q4 2018 | $2,000 | -97.4% | 174 | -97.5% | 0.00% | – |
| Q3 2018 | $77,000 | +2.7% | 6,885 | -26.8% | 0.00% | – |
| Q4 2017 | $75,000 | – | 9,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |